Onderneming Guardion Health Sciences Inc Nasdaq
Aandelen
US40145Q2030
Farmaceutische producten
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Nutritional Supplements
97,2
%
| - | - | 12 | 97,2 % | - |
Ocular
2,8
%
| - | - | 0 | 2,8 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
North America
100,0
%
| 11 | 99,8 % | 12 | 100,0 % | +11,04% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jan Hall
CEO | Chief Executive Officer | - | 19-06-23 |
Chairman | 72 | 30-06-15 | |
Katie Cox
AUD | Comptroller/Controller/Auditor | - | 25-07-23 |
Susan Klein
PRN | Corporate Officer/Principal | - | - |
Craig Sheehan
PRN | Corporate Officer/Principal | 53 | 03-06-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 72 | 30-06-15 | |
Mark Goldstone
BRD | Director/Board Member | 60 | 01-06-15 |
Donald Gagliano
BRD | Director/Board Member | 71 | 09-04-19 |
Michaela Griggs
BRD | Director/Board Member | - | 09-12-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 284 156 | 1 029 559 ( 80,17 %) | 0 | 80,17 % |
Bedrijfsgegevens
Guardion Health Sciences, Inc.
2925 Richmond Avenue Suite 1200
77098, Houston
+800 873 5141
http://www.guardionhealth.comSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+31,37% | 588 mld. | |
-2,79% | 364 mld. | |
+20,33% | 326 mld. | |
+5,45% | 285 mld. | |
+14,83% | 239 mld. | |
+9,93% | 210 mld. | |
-6,95% | 200 mld. | |
+10,97% | 167 mld. | |
-0,03% | 161 mld. |